Xvivo Perfusion

Xvivo Perfusion AB develops and markets advanced organ perfusion systems—XVIVO Ex‑Vivo Lung Perfusion platform, Kidney Assist, and transport solutions—supporting donor assessment and transplantation worldwide, positioning it as a technology leader in regenerative medicine.

Headquarters: Sweden (SWE)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Medical Equipment Manufacturing

Employees: 200
HQ: Mölndal

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
XVIVO	Xvivo Perfusion Cap: 7.0B \| P/E: 238.1	EQUITY	STO	SEK	SE0004840718	Active	📈